Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease

Mary Ann A. DeMichele-Sweet, Lambertus Klei, Byron Creese, Elise A. Weamer, Lora McClain, Rebecca Sims, Isabel Hernandez, Sonia Moreno-Grau, Lluís Tárraga, Mèrce Boada, Emilio Alarcón-Martin, Sergi Valero, NIA-LOAD Family Based Study Consortium, Alzheimers Disease Genetics Consortium ADGC, Yushi Liu, Basavaraj Hooli, Dag Aarsland, Geir Selbaek, Sverre Bergh, Arvid Rongve, Ingvild Saltvedt, Håvard Skjellegrind, Bo Engdahl, Eystein Stordal, View ORCID ProfileOle Andreassen, Srdjan Djurovic, Lavinia Athanasiu, Davide Seripa, Barbara Borroni, Diego Albani, Gianluigi Forloni, Patrizia Mecocci, Alessandro Serretti, Diana de Ronchi, Antonis Politis, Giulia Paroni, AddNeuroMed Consortium, Julie Williams, Richard Mayeux, Tatiana Foroud, Agustín Ruiz, View ORCID ProfileClive Ballard, Oscar L. Lopez, M. Ilyas Kamboh, Bernie Devlin, View ORCID ProfileRobert A. Sweet
doi: https://doi.org/10.1101/2020.08.07.20139261
Mary Ann A. DeMichele-Sweet
1 University of Pittsburgh;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sweetma@upmc.edu
Lambertus Klei
1 University of Pittsburgh;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kleilx@upmc.edu
Byron Creese
2 University of Exeter Medical School;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: b.creese@exeter.ac.uk
Elise A. Weamer
1 University of Pittsburgh;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: weamerea@upmc.edu
Lora McClain
1 University of Pittsburgh;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mcclainll2@upmc.edu
Rebecca Sims
3 Cardiff University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: simsrc@cardiff.ac.uk
Isabel Hernandez
4 Universitat Internacional de Catalunya and National Institute of Health Carlos III;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ihernandez@fundacioace.org
Sonia Moreno-Grau
4 Universitat Internacional de Catalunya and National Institute of Health Carlos III;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: smoreno@fundacioace.com
Lluís Tárraga
4 Universitat Internacional de Catalunya and National Institute of Health Carlos III;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ltarraga@fundacioace.org
Mèrce Boada
4 Universitat Internacional de Catalunya and National Institute of Health Carlos III;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mboada@fundacioace.org
Emilio Alarcón-Martin
5 Universitat Internacional de Catalunya;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ealarcon@fundacioace.org
Sergi Valero
4 Universitat Internacional de Catalunya and National Institute of Health Carlos III;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: svalero@fundacioace.org
Yushi Liu
6 Eli Lilly and Company;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: liu_yushi@lilly.com
Basavaraj Hooli
6 Eli Lilly and Company;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: raj.hooli@lilly.com
Dag Aarsland
7 King's College London and Stavanger University Hospital;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dag.aarsland@kcl.ac.uk
Geir Selbaek
8 Vestfold Hospital Trust, Oslo University Hospital, and University of Oslo;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: geir.selbaek@aldringoghelse.no
Sverre Bergh
9 Innlandet Hospital Trust;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sverre.bergh@sykehuset-innlandet.no
Arvid Rongve
10 Helse Fonna and University of Bergen;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arvid.rongve@helse-fonna.no
Ingvild Saltvedt
11 University Hospital of Trondheim and Norwegian University of Science and Technology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ingvild.saltvedt@ntnu.no
Håvard Skjellegrind
12 Norwegian University of Science and Technology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: havard.skjellegrind@ntnu.no
Bo Engdahl
13 Norwegian Institute of Public Health;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bolars.engdahl@fhi.no
Eystein Stordal
12 Norwegian University of Science and Technology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: eystein.stordal@helse-nordtrondelag.no
Ole Andreassen
14 Oslo University Hospital and University of Oslo;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ole Andreassen
  • For correspondence: ole.andreassen@medisin.uio.no
Srdjan Djurovic
15 Oslo University Hospital and University of Bergen;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: srdjan.djurovic@medisin.uio.no
Lavinia Athanasiu
16 University of Oslo;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lavinia.athanasiu@medisin.uio.no
Davide Seripa
17 Fondazione IRCCS "Casa Sollievo della Sofferenza";
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dseripa@operapadrepio.it
Barbara Borroni
18 University of Brescia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: barbara.borroni@unibs.it
Diego Albani
19 Istituto di Ricerche Farmacologiche Mario Negri IRCCS;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: diego.albani@marionegri.it
Gianluigi Forloni
19 Istituto di Ricerche Farmacologiche Mario Negri IRCCS;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gianluigi.forloni@marionegri.it
Patrizia Mecocci
20 University of Perugia (Italy);
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: patrizia.mecocci@unipg.it
Alessandro Serretti
21 University of Bologna;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alessandro.serretti@unibo.it
Diana de Ronchi
21 University of Bologna;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: diana.deronchi@unibo.it
Antonis Politis
22 Eginition Hospital and National and Kapodistrian University of Athens;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: apolitis@med.uoa.gr
Giulia Paroni
17 Fondazione IRCCS "Casa Sollievo della Sofferenza";
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gparoni@operapadrepio.it
Julie Williams
3 Cardiff University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: williamsj@cardiff.ac.uk
Richard Mayeux
23 Columbia University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rpm2@columbia.edu
Tatiana Foroud
24 Indiana University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tforoud@iu.edu
Agustín Ruiz
4 Universitat Internacional de Catalunya and National Institute of Health Carlos III;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aruiz@fundacioace.com
Clive Ballard
25 University of Exeter Medical School and Exeter and King's College Consortium for Genetics and Neuropsychiatric Symptoms in Dementia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Clive Ballard
  • For correspondence: c.ballard@exeter.ac.uk
Oscar L. Lopez
1 University of Pittsburgh;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lopezol@upmc.edu
M. Ilyas Kamboh
1 University of Pittsburgh;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kamboh@pitt.edu
Bernie Devlin
1 University of Pittsburgh;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: devlinbj@upmc.edu
Robert A. Sweet
1 University of Pittsburgh;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert A. Sweet
  • For correspondence: sweetra@upmc.edu
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD+P), affecting ~ 40% to 60% of individuals with AD. AD+P identifies a subgroup of AD patients with poor outcomes. The strongest clinical predictor of AD+P is a greater degree of cognitive impairment than in AD subjects without psychosis (AD-P). Other frequently replicated correlates of AD+P include elevated depressive symptoms. Although the estimated heritability of psychosis in AD is 61%, the underlying genetic sources of this risk are not known. We report a genome-wide meta-analysis of 12,317 AD subjects, with and without psychosis. Results showed common genetic variation accounted for a significant portion of heritability. Two loci, one in the gene ENPP6 (best SNP rs9994623, O.R. (95%CI) 1.16 (1.10, 1.22), p=1.26x10-8) and one spanning the 3-prime-UTR of an alternatively spliced transcript of SUMF1 (best SNP rs201109606, O.R. 0.65 (0.56-0.76), p=3.24x10-8), had genome-wide significant associations with the risk of psychosis in AD. Psychosis risk in AD demonstrated negative genetic correlations with cognitive and educational attainment and positive genetic correlation with depressive symptoms. We had previously observed a negative genetic correlation with schizophrenia, instead we now found a stronger negative correlation with the related phenotype of bipolar disorder. Psychosis risk in AD was not genetically correlated with AD or other neurodegenerative diseases. These findings provide the first unbiased identification of the association of psychosis in AD with common genetic variation and provide insights into its genetic architecture. Study of the genetic mechanisms underlying the associations of loci in ENPP6 and SUMF1 with psychosis in AD are warranted.

Competing Interest Statement

Yushi Liu and Basavaraj Hooli are currently employed by and holding stock in Eli Lilly and Company. Dr. Clive Ballard reports grants and personal fees from Acadia pharmaceutical company, grants and personal fees from Lundbeck, personal fees from Roche, personal fees from Otsuka, personal fees from Biogen, personal fees from Eli Lilly, personal fees from Novo Nordisk, personal fees from AARP, grants and personal fees from Synexus, personal fees from Exciva, outside the submitted work. Dr. Oscar Lopez served as a consultant for Grifols, Inc. Dr Saltvedt has been investigator in the drug trial Boehringer‐Ingelheim 1346.0023 Ole A. Andreassen: Consultant to HEALTHLYTIX, speaker honoraria from Lundbeck.

Clinical Protocols

https://clinicaltrials.gov/ct2/show/NCT00594568

https://clinicaltrials.gov/ct2/show/NCT00762411

https://clinicaltrials.gov/ct2/show/NCT00905372

https://clinicaltrials.gov/ct2/show/NCT00904683

https://clinicaltrials.gov/ct2/show/NCT00051909

https://clinicaltrials.gov/ct2/show/NCT00843518

https://clinicaltrials.gov/ct2/show/NCT00191009

https://clinicaltrials.gov/ct2/show/NCT01900665

Funding Statement

RAS: AG027224 and MH116046 BD: MH057881 MIK: AG030653 and AG041718 OLL: AG066468 MB and AR: European Union/EFPIA Innovative Medicines Initiative Joint Undertaking ADAPTED-Grant No 115975, MOPEAD-Grant No. 115985, PI13/02434, I16/01861, PI17/01474, PI19/01301, and CIBERNED grant 2019/08 The genotyping service to generate GRatACE GWAS data: grant PT17/0019 of the PE I+D+i 2013-2016, funded by ISCIII and ERDF National Centralized Repository for Alzheimers Disease and Related Dementias (NCRAD): U24 AG021886 The NACC database: NIA/NIH Grant U01 AG016976 The Alzheimers Disease Genetics Consortium (ADGC): NIA grants U01AG032984 and RC2AG036528 National Institute on Aging Alzheimers Disease Data Storage Site (NIAGADS): U24-AG041689-01 NEXGENS: National Institute on Aging of the National Institutes of Health R01AG067015 AddNeuroMed: EU FP6 program as part of InnoMed NorCog: South-Eastern Norway Regional Health Authority and Norwegian National Advisory Unit on Ageing and Health HMS: the Norwegian Institute of Public Health, the Norwegian University of Science and Technology (NTNU), Nord-Tr&oslashndelag Hospital Trust, and Innlandet Hospital Trust REDIC-NH: Age-Related Functional Decline and Disease, Innlandet Hospital Trust, and the Norwegian Health Directorate NIMH: U01 MH46281, U01 MH46290, U01 MH46373 Ole A. Andreassen: Research Council of Norway #223273

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Collection of all clinical data and genetic samples were approved by the Institutional Review Board or Medical Ethics Committee, as appropriate, for each source program

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be submitted to NIAGADS (https://www.niagads.org) upon acceptance of peer-reviewed manuscript.

http://csg.sph.umich.edu/abecasis/metal/index.html

http://www.compgen.pitt.edu/GemTools/GemTools.htm

https://www.cog-genomics.org/plink2/

https://ftp.ncbi.nih.gov/snp/redesign/latest_release/VCF/

http://ldsc.broadinstitute.org/ldhub/

https://imputation.sanger.ac.uk

https://www.med.unc.edu/pgc/

https://www.well.ox.ac.uk/~wrayner/tools/

https://www.synapse.org/#!Synapse:syn16984815

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease
Mary Ann A. DeMichele-Sweet, Lambertus Klei, Byron Creese, Elise A. Weamer, Lora McClain, Rebecca Sims, Isabel Hernandez, Sonia Moreno-Grau, Lluís Tárraga, Mèrce Boada, Emilio Alarcón-Martin, Sergi Valero, NIA-LOAD Family Based Study Consortium, Alzheimers Disease Genetics Consortium ADGC, Yushi Liu, Basavaraj Hooli, Dag Aarsland, Geir Selbaek, Sverre Bergh, Arvid Rongve, Ingvild Saltvedt, Håvard Skjellegrind, Bo Engdahl, Eystein Stordal, Ole Andreassen, Srdjan Djurovic, Lavinia Athanasiu, Davide Seripa, Barbara Borroni, Diego Albani, Gianluigi Forloni, Patrizia Mecocci, Alessandro Serretti, Diana de Ronchi, Antonis Politis, Giulia Paroni, AddNeuroMed Consortium, Julie Williams, Richard Mayeux, Tatiana Foroud, Agustín Ruiz, Clive Ballard, Oscar L. Lopez, M. Ilyas Kamboh, Bernie Devlin, Robert A. Sweet
medRxiv 2020.08.07.20139261; doi: https://doi.org/10.1101/2020.08.07.20139261
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease
Mary Ann A. DeMichele-Sweet, Lambertus Klei, Byron Creese, Elise A. Weamer, Lora McClain, Rebecca Sims, Isabel Hernandez, Sonia Moreno-Grau, Lluís Tárraga, Mèrce Boada, Emilio Alarcón-Martin, Sergi Valero, NIA-LOAD Family Based Study Consortium, Alzheimers Disease Genetics Consortium ADGC, Yushi Liu, Basavaraj Hooli, Dag Aarsland, Geir Selbaek, Sverre Bergh, Arvid Rongve, Ingvild Saltvedt, Håvard Skjellegrind, Bo Engdahl, Eystein Stordal, Ole Andreassen, Srdjan Djurovic, Lavinia Athanasiu, Davide Seripa, Barbara Borroni, Diego Albani, Gianluigi Forloni, Patrizia Mecocci, Alessandro Serretti, Diana de Ronchi, Antonis Politis, Giulia Paroni, AddNeuroMed Consortium, Julie Williams, Richard Mayeux, Tatiana Foroud, Agustín Ruiz, Clive Ballard, Oscar L. Lopez, M. Ilyas Kamboh, Bernie Devlin, Robert A. Sweet
medRxiv 2020.08.07.20139261; doi: https://doi.org/10.1101/2020.08.07.20139261

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (74)
  • Dermatology (49)
  • Emergency Medicine (148)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (176)
  • Epidemiology (4908)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (690)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (325)
  • Health Systems and Quality Improvement (209)
  • Hematology (87)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5414)
  • Intensive Care and Critical Care Medicine (334)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (130)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (203)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (788)
  • Public and Global Health (1833)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (258)
  • Rheumatology (88)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (39)